In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Genocea Biosciences closes $23mm Series A round

Executive Summary

Vaccines company Genocea Biosciences raised $23mm in its Series A round led by first-time backer SR One. Other new investors Auriga Partners, Cycad Group, and Alexandria Real Estate Equities were joined by existing shareholders Lux Capital Management, Polaris Venture Partners, and Morningside Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies